Well, it's harder and harder to believe in a company that releases PRs that don't tell us much and often rehash the past while we do not get news on some of the central focus of the company in a timely manner.
Anyone remember that HemaX orphan drug status was filed for in January 2016! Here we are in November, 2 months from when they last responded to the FDA with further data and nothing, we have no update.
DCellVax went for months without filing a response to FDA and without news. 2 months ago, PR stated that they had filed FDA response with data. Once again - no news, no update.
Since FDA is supposed to respond to company within 30 days of getting the new filings, why do we not have a company update? Whether good or bad, a standard company run by managers who care about stockholder interest and such would keep us updated, but alas, even with hiring of a company to promote the company, another company to seek out money and partners, there is little regular business relations conducted here.
My best hope was the hiring of the Ichims and, at the time, new energy and business practices with conference attendance, PRs on presentations and developments, new labs contracted to work in and new relationships that seemed promising with Dr. Kesari and NIH/NCATS. That was 2015.
Suddenly, this developing company in 2016 has neither Dr. on board whose science and patents the company's main products are based on and we haven't heard of, from or what happened to the main protagonist of 2015, Christine Ichim. We know T. Ichim left/fired and now is replaced.
We haven't heard much about Dr. Kesari who was contracted to be paid 40K for performing data on DCellVax and expanding the IND.
We get bits and pieces of news/PRs that are followed by massive selling into the buying. And since those who hold the most shares are insiders, they also know the most about where the company is at. All the "positive" development of the past year has driven the price lower. I no longer can stomach that as "progress". It's an ill sign of where the company is at.
I no longer have any faith in the capability of RGBP to function and develop into a successful company.
AI
